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Source of material
Te on-lined hydrothermal autoclave reactor. The reactor was heated to 433 K for 96 h under autogenous pressure. After cooling, colorless single crystals of title compound suitable for X-ray analysis were obtained.
Discussion
Sara oxacin (HSara), C 20 H17F 2 N 3 O 3 (systematic name 6-uoro-1-(4-uorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid), is a member of the uoroquinolone family of antibiotics, widely used in veterinary clinical practice because of its wide antibiotic spectrum and its excellent bactericidal activity [1] .
Our interest in sara oxacin and related uoroquinolones is focused on their potential as multidentate/bridging ligands in coordination chemistry. Our aim is trying to prepare a corresponding magnesium(II) complex, but the title compound was obtained.
The title structure is built up from mono protonated spar oxacin cations and 1,4-benzenedicarboxylate anions in the ratio 2:1. There are two intermolecular N -H· · · O hydrogen bonds from the positively charged piperazinium ring towards the carboxylate groups of two counter anions.
